SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-011119
Filing Date
2020-04-21
Accepted
2020-04-21 21:59:53
Documents
1
Period of Report
2020-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7279
  Complete submission text file 0000899243-20-011119.txt   8671
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Issuer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SEATTLE GENETICS, INC. 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
HIMES VAUGHN B (Reporting) CIK: 0001361966 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 20806546